Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of Alberta
- Study ID
- NCT03193151
- Status
- Recruiting
Conditions
- Liver Dysfunction
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- liver biopsy — PROCEDURE5 mm fragment of liver transplant biopsy taken for clinical indication
Study Details
INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.
Key Dates
- Start date
- Dec 19, 2017
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 300 participants (estimated)
Primary Outcome Measure
Assign molecular scores (probability) of T cell mediated rejection, antibody mediated rejection in liver transplant biopsies, in a reference set of 100 biopsies [ Time Frame: two years ]
Central Contacts
- Konrad S Famulski, PhD1 780 492 1725
- Robert Polakowski, PhD1 780 492 5091
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California San Francisco, Transplant Research Unit | San Francisco | California | 94143 | - |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | - |
| University of Maryland School of Medicine | Baltimore | Maryland | 21201 | - |
| Henry Ford Transplant Institute | Detroit | Michigan | 48202 | Dilip Moonka, MD Sierra Foley Marwan Abouljoud, MD (PRINCIPAL_INVESTIGATOR) |
| Vanderbilt University Medical Center, Vanderbilt Transplant Center | Nashville | Tennessee | 37232 | - |
| Baylor University Medical Center, Annette C. and Harold C. Simmons Transplant Institute | Dallas | Texas | 75246 | - |
| Transplant Surgery, VCU Medical Center | Richmond | Virginia | 23298 | - |
| Division of Transplant Surgery, University of Washington | Seattle | Washington | 98195 | - |
Find similar trials in San Francisco, CA
By research site
University of California San Francisco, Transplant Research Unit· San Francisco, CANorthwestern Memorial Hospital· Chicago, ILUniversity of Maryland School of Medicine· Baltimore, MDHenry Ford Transplant Institute· Detroit, MIVanderbilt University Medical Center, Vanderbilt Transplant Center· Nashville, TNBaylor University Medical Center, Annette C. and Harold C. Simmons Transplant Institute· Dallas, TX
Related Studies
- Global Utilization And Registry Database for Improved preservAtion of doNor LiversEnrolling By Invitation · Paragonix Technologies · Birmingham, Alabama
- A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver FunctionPHASE1 · Recruiting · Eli Lilly and Company · Miami, Florida